Suppr超能文献

心肺功能表现能力和气道微生物组在食管闭锁患者初次修复术后。

Cardiorespiratory performance capacity and airway microbiome in patients following primary repair of esophageal atresia.

机构信息

Department of Paediatric and Adolescent Surgery, Medical University of Graz, Graz, Austria.

Core Facility Molecular Biology, Center for Medical Research, Medical University of Graz, Graz, Austria.

出版信息

Pediatr Res. 2021 Jul;90(1):66-73. doi: 10.1038/s41390-020-01222-7. Epub 2020 Nov 6.

Abstract

BACKGROUND

Patients following repair of an esophageal atresia (EA) or tracheoesophageal fistula (TEF) carry an increased risk of long-term cardiopulmonary malaise. The role of the airway microbiome in EA/TEF patients remains unclear.

METHODS

All EA/TEF patients treated between 1980 and 2010 were invited to a prospective clinical examination, spirometry, and spiroergometry. The airway microbiome was determined from deep induced sputum by 16 S rRNA gene sequencing. The results were compared to a healthy age- and sex-matched control group.

RESULTS

Nineteen EA/TEF patients with a mean age of 24.7 ± 7 years and 19 age- and sex-matched controls were included. EA/TEF patients showed a significantly lower muscle mass, lower maximum vital capacity (VC), and higher rates of restrictive ventilation disorders. Spiroergometry revealed a significantly lower relative performance capacity and lower peak VO in EA/TEF patients. Alpha- and beta-diversity of the airway microbiome did not differ significantly between the two groups. Linear discriminant effect size analysis revealed significantly enriched species of Prevotella_uncultured, Streptococcus_anginosus, Prevotella_7_Prevotella_enoeca, and Mogibacterium_timidum.

CONCLUSION

EA/TEF patients frequently suffer from restrictive ventilation disorders and impaired cardiopulmonary function associated with minor alterations of the airway microbiome. Long-term examinations of EA/TEF patients seem to be necessary in order to detect impaired cardiopulmonary function.

IMPACT

The key messages of the present study are a significantly decreased VC and exercise performance, as well as airway microbiome differences in EA/TEF patients. This study is the first to present parameters of lung function and exercise performance in combination with airway microbiome analysis with a mean follow-up of 24 years in EA/TEF patients. Prospective, long-term studies are needed to unravel possible interactions between alterations of the airway microbiome and impaired pulmonary function in EA/TEF patients.

摘要

背景

食管闭锁(EA)或气管食管瘘(TEF)修复后的患者存在长期心肺不适的风险增加。气道微生物组在 EA/TEF 患者中的作用尚不清楚。

方法

所有 1980 年至 2010 年间接受治疗的 EA/TEF 患者均被邀请参加前瞻性临床检查、肺活量测定和运动肺功能测定。通过 16S rRNA 基因测序从深部诱导痰中确定气道微生物组。结果与年龄和性别匹配的健康对照组进行比较。

结果

19 例 EA/TEF 患者,平均年龄 24.7±7 岁,19 例年龄和性别匹配的对照组纳入研究。EA/TEF 患者的肌肉质量明显较低,最大肺活量(VC)较低,限制性通气障碍的发生率较高。运动肺功能测定显示 EA/TEF 患者的相对运动能力和峰值 VO 明显较低。两组之间气道微生物组的α和β多样性无显著差异。线性判别效应量分析显示,普雷沃氏菌未培养、酿脓链球菌、普雷沃氏菌 7_普雷沃氏菌肠杆菌和莫格杆菌的丰度显著增加。

结论

EA/TEF 患者常患有限制性通气障碍和心肺功能受损,与气道微生物组的轻微改变有关。为了检测心肺功能受损,对 EA/TEF 患者进行长期检查似乎是必要的。

影响

本研究的主要发现是 EA/TEF 患者的 VC 和运动表现显著降低,以及气道微生物组存在差异。这是第一项在 EA/TEF 患者中进行的,平均随访 24 年,同时进行肺功能和运动表现参数以及气道微生物组分析的研究。需要前瞻性、长期研究来揭示 EA/TEF 患者气道微生物组改变与肺功能受损之间可能的相互作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df78/8370877/03d879b426b5/41390_2020_1222_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验